Susquehanna International Group
KZIA

Susquehanna International Group’s Kazia Therapeutics KZIA Stock Holding History

Susquehanna International Group’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$431K Buy
+30,600
New +$373K ﹤0.01% 10246
2021
Q3 		– Sell
-484
Closed -$239K – 13188
2021
Q2 		$239K Sell
484
-652
-57% -$344K ﹤0.01% 11229
2021
Q1 		$704K Buy
+1,136
New +$594K ﹤0.01% 8643

Other funds holding KZIA

BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
FLPIM
F.L. Putnam Investment Management Lynnfield, Massachusetts $8.39B AUM 37.75% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
DIG
Dauntless Investment Group Etna, New Hampshire $127M AUM 42.43% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Ensign Peak Advisors
Ensign Peak Advisors Salt Lake City, Utah $60.8B AUM 42.06% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Susquehanna International Group's KZIA Position: Q2 2026 in Review

Susquehanna International Group opened a new position in Kazia Therapeutics (KZIA) in Q2 2026: 50,616 shares worth $713K. The stake represents ﹤0.01% of the portfolio and ranks #9058 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in KZIA as recently as Q2 2024.

Susquehanna International Group first reported a position in KZIA in Q3 2018 and has held it in 9 quarters since. 35 funds tracked by Wall St. Rank hold KZIA as of Q2 2026.

  • Susquehanna International Group held 50,616 shares of Kazia Therapeutics worth $713K as of Q2 2026.
  • Kazia Therapeutics was a new Susquehanna International Group position in Q2 2026.
  • Kazia Therapeutics made up ﹤0.01% of Susquehanna International Group's portfolio in Q2 2026, its #9058 holding.
  • Susquehanna International Group first reported a position in Kazia Therapeutics in Q3 2018 and has held it in 9 quarters since.
  • 35 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q2 2026.

Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.